Search Results - "Curcumin - adverse effects"
-
1
Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers
ISSN: 0344-5704, 1432-0843, 1432-0843Published: Berlin/Heidelberg Springer-Verlag 01.01.2012Published in Cancer chemotherapy and pharmacology (01.01.2012)“… After an interval of 2 weeks, the same subjects then received THERACURMIN at a single dose of 210…”
Get full text
Journal Article -
2
oral bioavailability of curcumin from micronized powder and liquid micelles is significantly increased in healthy humans and differs between sexes
ISSN: 1613-4125, 1613-4133, 1613-4133Published: Weinheim Blackwell Publishing Ltd 01.03.2014Published in Molecular nutrition & food research (01.03.2014)“… METHODS AND RESULTS: In this crossover study, healthy subjects (13 women, 10 men) took, in random order, a single oral dose of 500 mg curcuminoids as native powder, micronized powder, or liquid micelles…”
Get full text
Journal Article -
3
Potential of Curcumin in Skin Disorders
ISSN: 2072-6643, 2072-6643Published: Switzerland MDPI AG 10.09.2019Published in Nutrients (10.09.2019)“…Curcumin is a compound isolated from turmeric, a plant known for its medicinal use. Recently, there is a growing interest in the medical community in…”
Get full text
Journal Article -
4
Efficacy and Safety of Phytosomal Curcumin in Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Trial
ISSN: 2194-9379, 2194-9387Published: Stuttgart · New York Georg Thieme Verlag KG 01.04.2017Published in Drug research (01.04.2017)“… This study aimed to evaluate the efficacy and safety of supplementation with phytosomal curcumin in subjects with NAFLD…”
Get full text
Journal Article -
5
Eight Weeks of a High Dose of Curcumin Supplementation May Attenuate Performance Decrements Following Muscle-Damaging Exercise
ISSN: 2072-6643, 2072-6643Published: Switzerland MDPI AG 23.07.2019Published in Nutrients (23.07.2019)“…Background: It is known that unaccustomed exercise—especially when it has an eccentric component—causes muscle damage and subsequent performance decrements…”
Get full text
Journal Article -
6
ProspeCtive study to evaluate efficacy, safety and tOlerability of dietary supplemeNT of Curcumin (BCM95) in subjects with Active relapsing MultIple Sclerosis treated with subcutaNeous Interferon beta 1a 44 mcg TIW (CONTAIN): A randomized, controlled trial
ISSN: 2211-0348, 2211-0356, 2211-0356Published: Netherlands Elsevier B.V 01.11.2021Published in Multiple sclerosis and related disorders (01.11.2021)“… Here we investigated the efficacy of curcumin, a naturally occurring poly-phenolic phytochemical with potent anti-inflammatory and antioxidant properties, in subjects under treatment with IFN…”
Get full text
Journal Article -
7
Short-term Curcuminoid Supplementation for Chronic Pulmonary Complications due to Sulfur Mustard Intoxication: Positive Results of a Randomized Double-blind Placebo-controlled Trial
ISSN: 2194-9387, 2194-9387Published: Germany 01.11.2015Published in Drug research (01.11.2015)“…). The present pilot study aimed to investigate the clinical effects of supplementation with curcuminoids on markers of pulmonary function and systemic inflammation in SM-intoxicated subjects…”
Get more information
Journal Article -
8
Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies
ISSN: 0007-1145, 1475-2662, 1475-2662Published: Cambridge, UK Cambridge University Press 14.06.2010Published in British journal of nutrition (14.06.2010)“… Curcumin is non-toxic to human subjects at high doses. It is a complex molecule with multiple biological targets and different cellular effects…”
Get full text
Journal Article -
9
A Randomized Double-Blind Placebo-Controlled Phase IIB Trial of Curcumin in Oral Leukoplakia
ISSN: 1940-6215Published: United States 01.08.2016Published in Cancer prevention research (Philadelphia, Pa.) (01.08.2016)“… Subjects with oral leukoplakia (n = 223) were randomized (1:1 ratio) to receive orally, either…”
Get more information
Journal Article -
10
A combination of hydroxytyrosol, omega-3 fatty acids and curcumin improves pain and inflammation among early stage breast cancer patients receiving adjuvant hormonal therapy: results of a pilot study
ISSN: 1699-048X, 1699-3055, 1699-3055Published: Cham Springer International Publishing 01.04.2019Published in Clinical & translational oncology (01.04.2019)“…Purpose Breast cancer patients receiving hormonal therapies face risks of relapse, increased rates of cardiovascular events, and toxicities of therapy such as…”
Get full text
Journal Article -
11
Efficacy and safety of curcumin in primary sclerosing cholangitis: an open label pilot study
ISSN: 0036-5521, 1502-7708, 1502-7708Published: England Taylor & Francis 04.05.2019Published in Scandinavian journal of gastroenterology (04.05.2019)“…Goals: To assess if curcumin improves markers of cholestasis among subjects with primary sclerosing cholangitis (PSC). Background…”
Get full text
Journal Article -
12
Safety, tolerability and pharmacokinetics of liposomal curcumin in healthy humans
ISSN: 0946-1965Published: Germany 01.01.2015Published in International journal of clinical pharmacology and therapeutics (01.01.2015)“… In this phase I clinical trial we investigated the pharmacokinetics, safety, and tolerability of intravenously administered liposomal curcumin in healthy subjects…”
Get more information
Journal Article -
13
Human Pharmacokinetics of High Dose Oral Curcumin and Its Effect on Heme Oxygenase-1 Expression in Healthy Male Subjects
ISSN: 2314-6133, 2314-6141, 2314-6141Published: Cairo, Egypt Hindawi Puplishing Corporation 01.01.2014Published in BioMed research international (01.01.2014)“… We investigated the inducibility of HO-1 by orally administered curcumin in healthy male subjects and its correlation with the GT length polymorphism. Methods…”
Get full text
Journal Article -
14
Sensitization of GSH synthesis by curcumin curtails acrolein-induced alveolar epithelial apoptosis via Keap1 cysteine conjugation: A randomized controlled trial and experimental animal model of pneumonitis
ISSN: 2090-1232, 2090-1224, 2090-1224Published: Egypt Elsevier B.V 01.04.2023Published in Journal of Advanced Research (01.04.2023)“…[Display omitted] •Curcumin improves systemic inflammation in subjects residing in an air-polluted area…”
Get full text
Journal Article -
15
Curcumin effects on blood lipid profile in a 6-month human study
ISSN: 1043-6618, 1096-1186Published: Netherlands Elsevier Ltd 01.12.2007Published in Pharmacological research (01.12.2007)“… This study investigated the effects of consuming curcumin on the serum lipid profile in men and women. Elderly subjects ( n = 36…”
Get full text
Journal Article -
16
A randomized, placebo-controlled, double-blind clinical trial of curcuminoids in oral lichen planus
ISSN: 0944-7113, 1618-095XPublished: Germany Elsevier GmbH 01.08.2007Published in Phytomedicine (Stuttgart) (01.08.2007)“… The first interim analysis was conducted in October 2004 using data from the first 33 subjects…”
Get full text
Journal Article -
17
Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa)
ISSN: 1075-5535Published: United States 01.02.2003Published in The journal of alternative and complementary medicine (New York, N.Y.) (01.02.2003)“…Tumeric is a spice that comes from the root Curcuma longa, a member of the ginger family, Zingaberaceae. In Ayurveda (Indian traditional medicine), tumeric has…”
Get more information
Journal Article